000186482 001__ 186482
000186482 005__ 20220930130037.0
000186482 0247_ $$2doi$$a10.3390/molecules20010470
000186482 0247_ $$2WOS$$aWOS:000348319000028
000186482 0247_ $$2Handle$$a2128/9012
000186482 037__ $$aFZJ-2015-00556
000186482 041__ $$aEnglish
000186482 082__ $$a540
000186482 1001_ $$0P:(DE-Juel1)131830$$aKügler, Fabian$$b0
000186482 245__ $$a4-[18F]Fluorophenylpiperazines by Improved Hartwig-Buchwald N-Arylation of 4-[18F]fluoroiodobenzene, Formed via Hypervalent λ3-Iodane Precursors: Application to Build-Up of the Dopamine D4 Ligand [18F]FAUC 316
000186482 260__ $$aBasel$$bMDPI75390$$c2015
000186482 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1437642303_19509
000186482 3367_ $$2DataCite$$aOutput Types/Journal article
000186482 3367_ $$00$$2EndNote$$aJournal Article
000186482 3367_ $$2BibTeX$$aARTICLE
000186482 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000186482 3367_ $$2DRIVER$$aarticle
000186482 520__ $$aSubstituted phenylpiperazines are often neuropharmacologically active compounds and in many cases are essential pharmacophores of neuroligands for different receptors such as D2-like dopaminergic, serotoninergic and other receptors. Nucleophilic, no-carrier-added (n.c.a.) 18F-labelling of these ligands in an aromatic position is desirable for studying receptors with in vivo molecular imaging. 1-(4-[18F]Fluorophenyl)piperazine was synthesized in two reaction steps starting by 18F-labelling of a iodobenzene-iodonium precursor, followed by Pd-catalyzed N-arylation of the intermediate 4-[18F]fluoro-iodobenzene. Different palladium catalysts and solvents were tested with particular attention to the polar solvents dimethylformamide (DMF) and dimethylsulfoxide (DMSO). Weak inorganic bases like potassium phosphate or cesium carbonate seem to be essential for the arylation step and lead to conversation rates above 70% in DMF which is comparable to those in typically used toluene. In DMSO even quantitative conversation was observed. Overall radiochemical yields of up to 40% and 60% in DMF and DMSO, respectively, were reached depending on the labelling yield of the first step. The fluorophenylpiperazine obtained was coupled in a third reaction step with 2-formyl-1H-indole-5-carbonitrile to yield the highly selective dopamine D4 ligand [18F]FAUC 316.
000186482 536__ $$0G:(DE-HGF)POF3-573$$a573 - Neuroimaging (POF3-573)$$cPOF3-573$$fPOF III$$x0
000186482 536__ $$0G:(DE-Juel1)HITEC-20170406$$aHITEC - Helmholtz Interdisciplinary Doctoral Training in Energy and Climate Research (HITEC) (HITEC-20170406)$$cHITEC-20170406$$x1
000186482 588__ $$aDataset connected to CrossRef, juser.fz-juelich.de
000186482 7001_ $$0P:(DE-Juel1)131818$$aErmert, Johannes$$b1$$eCorresponding author
000186482 7001_ $$0P:(DE-Juel1)156235$$aKaufholz, Peter$$b2
000186482 7001_ $$0P:(DE-Juel1)131816$$aCoenen, Heinrich Hubert$$b3
000186482 773__ $$0PERI:(DE-600)2008644-1$$a10.3390/molecules20010470$$gVol. 20, no. 1, p. 470 - 486$$n1$$p470 - 486$$tMolecules$$v20$$x1420-3049$$y2015
000186482 8564_ $$uhttps://juser.fz-juelich.de/record/186482/files/FZJ-2015-00556.pdf$$yOpenAccess
000186482 8767_ $$92014-12-18$$d2015-01-09$$eAPC$$jZahlung erfolgt$$pmolecules-66341$$zOriginalwährung CHF 1.620,-
000186482 909CO $$ooai:juser.fz-juelich.de:186482$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire$$pdnbdelivery
000186482 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000186482 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000186482 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000186482 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000186482 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000186482 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000186482 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000186482 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000186482 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences
000186482 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000186482 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000186482 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000186482 9141_ $$y2015
000186482 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-HGF)0$$aForschungszentrum Jülich GmbH$$b0$$kFZJ
000186482 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131818$$aForschungszentrum Jülich GmbH$$b1$$kFZJ
000186482 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)156235$$aForschungszentrum Jülich GmbH$$b2$$kFZJ
000186482 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131816$$aForschungszentrum Jülich GmbH$$b3$$kFZJ
000186482 9131_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000186482 920__ $$lyes
000186482 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000186482 9801_ $$aFullTexts
000186482 980__ $$ajournal
000186482 980__ $$aVDB
000186482 980__ $$aFullTexts
000186482 980__ $$aUNRESTRICTED
000186482 980__ $$aI:(DE-Juel1)INM-5-20090406
000186482 980__ $$aAPC